![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Radboud University Zorgverzekeraar CZ WINAp |
---|---|
Information provided by: | Radboud University |
ClinicalTrials.gov Identifier: | NCT00509717 |
The purpose of this study is to determine the effectiveness of maximal support of community pharmacies to implement a pharmaceutical care model for improving underprescription and treatment persistence regarding lipid-lowering medication in patients with cardiovascular disease.
Condition | Intervention |
---|---|
Cardiovascular Diseases |
Other: intensive implementation programme Other: control |
Study Type: | Interventional |
Study Design: | Health Services Research, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs. A Randomized Trial. |
Enrollment: | 70 |
Study Start Date: | October 2006 |
Study Completion Date: | March 2008 |
Primary Completion Date: | February 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
experimental: Experimental |
Other: intensive implementation programme
educational manual; interactive educational meeting tailored to individual needs; reminders and feedback by 3 newsletters and at least 3 telephone calls.
|
control: Active Comparator |
Other: control
educational manual
|
Cardiovascular disease is the main cause of death in large parts of the world. Next to life style changes, pharmaceutical treatment is a keystone in the treatment of cardiovascular disease. Despite the strong evidence for the effectiveness of lipid-lowering therapy, less than half of the people eligible are treated. With specific medication searches in the community pharmacy database, an easy tool for detecting patients who are undertreated is available. Based on this tool, a pharmaceutical care model for improving underprescription and treatment persistence regarding lipid-lowering medication in patients with cardiovascular disease was constructed.
Moreover, it is not known yet how to implement this pharmaceutical care model in community pharmacies effectively. With multifaceted interventions the behaviour of health professionals can be changed. In this study the effectiveness of a maximal support strategy, including interactive educational meetings, reminders, audit and feedback, is compared to a minimal implementation strategy.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:for patients:
Netherlands, NL | |
UMC St Radboud, Scientific Institute for Quality of Healthcare | |
Nijmegen, NL, Netherlands, 6500 HB |
Principal Investigator: | Peter G. de Smet, PhD | Radboud University |
Study Director: | Michel Wensing, PhD | Scientific Institute for Quality of Healthcare |
Responsible Party: | Scientific Institute for Quality of Healthcare ( Caroline van de Steeg-van Gompel ) |
Study ID Numbers: | WOK/WINAp/CZ-02 |
Study First Received: | February 28, 2007 |
Last Updated: | July 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00509717 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
quality of health care prescriptions, drug anticholesteremic agents community pharmacy services |
Cardiovascular Diseases |